Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
95 GBX | 0.00% | +0.53% | -8.21% |
Mar. 20 | ReNeuron appoints administrators as rescue talks fail | AN |
Mar. 20 | Transense Technologies plc Appoints Ryan Maughan as Managing Director | CI |
Sales 2024 * | 4.03M 4.98M | Sales 2025 * | 5.15M 6.37M | Capitalization | 14.46M 17.88M |
---|---|---|---|---|---|
Net income 2024 * | 1M 1.24M | Net income 2025 * | 1M 1.24M | EV / Sales 2024 * | 3.29 x |
Net cash position 2024 * | 1.2M 1.48M | Net cash position 2025 * | 2.5M 3.09M | EV / Sales 2025 * | 2.32 x |
P/E ratio 2024 * |
10.6
x | P/E ratio 2025 * |
8.89
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.57% |
1 week | +0.53% | ||
Current month | -7.32% | ||
1 month | -7.32% | ||
3 months | -5.00% | ||
6 months | -7.32% | ||
Current year | -8.21% |
Managers | Title | Age | Since |
---|---|---|---|
Ryan Maughan
CEO | Chief Executive Officer | 45 | 21-11-30 |
Melvyn Segal
DFI | Director of Finance/CFO | 69 | 07-12-09 |
Jordan Taylor
SAM | Sales & Marketing | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Nigel Rogers
CHM | Chairman | 62 | 15-07-27 |
Director/Board Member | 80 | 07-03-31 | |
Stephen Parker
BRD | Director/Board Member | 89 | 23-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 95 | 0.00% | 5,000 |
24-04-18 | 95 | +0.53% | 44,316 |
24-04-17 | 94.5 | +3.28% | 26,705 |
24-04-16 | 91.5 | -3.17% | 105,670 |
24-04-15 | 94.5 | 0.00% | 123,483 |
Delayed Quote London S.E., April 19, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.21% | 18.04M | |
+12.38% | 436M | |
+2.20% | 335M | |
-10.69% | 147M | |
+62.63% | 144M | |
-.--% | 139M | |
+173.00% | 107M | |
-2.06% | 78.44M | |
+51.49% | 53.28M |
- Stock Market
- Equities
- TRT Stock